Literature DB >> 33534562

Singlet Oxygen Formation vs Photodissociation for Light-Responsive Protic Ruthenium Anticancer Compounds: The Oxygenated Substituent Determines Which Pathway Dominates.

Fengrui Qu1, Robert W Lamb2, Colin G Cameron3, Seungjo Park4, Olaitan Oladipupo1, Jessica L Gray1, Yifei Xu1, Houston D Cole3, Marco Bonizzoni1, Yonghyun Kim4, Sherri A McFarland3, Charles Edwin Webster2, Elizabeth T Papish1.   

Abstract

Ruthenium complexes bearing protic diimine ligands are cytotoxic to certain cancer cells upon irradiation with blue light. Previously reported complexes of the type [(N,N)2Ru(6,6'-dhbp)]Cl2 with 6,6'-dhbp = 6,6'-dihydroxybipyridine and N,N = 2,2'-bipyridine (bipy) (1A), 1,10-phenanthroline (phen) (2A), and 2,3-dihydro-[1,4]dioxino[2,3-f][1,10]phenanthroline (dop) (3A) show EC50 values as low as 4 μM (for 3A) vs breast cancer cells upon blue light irradiation ( Inorg. Chem. 2017, 56, 7519). Herein, subscript A denotes the acidic form of the complex bearing OH groups, and B denotes the basic form bearing O- groups. This photocytotoxicity was originally attributed to photodissociation, but recent results suggest that singlet oxygen formation is a more plausible cause of photocytotoxicity. In particular, bulky methoxy substituents enhance photodissociation but these complexes are nontoxic ( Dalton Trans 2018, 47, 15685). Cellular studies are presented herein that show the formation of reactive oxygen species (ROS) and apoptosis indicators upon treatment of cells with complex 3A and blue light. Singlet oxygen sensor green (SOSG) shows the formation of 1O2 in cell culture for cells treated with 3A and blue light. At physiological pH, complexes 1A-3A are deprotonated to form 1B-3B in situ. Quantum yields for 1O2 (ϕΔ) are 0.87 and 0.48 for 2B and 3B, respectively, and these are an order of magnitude higher than the quantum yields for 2A and 3A. The values for ϕΔ show an increase with 6,6'-dhbp derived substituents as follows: OMe < OH < O-. TD-DFT studies show that the presence of a low lying triplet metal-centered (3MC) state favors photodissociation and disfavors 1O2 formation for 2A and 3A (OH groups). However, upon deprotonation (O- groups), the 3MLCT state is accessible and can readily lead to 1O2 formation, but the dissociative 3MC state is energetically inaccessible. The changes to the energy of the 3MLCT state upon deprotonation have been confirmed by steady state luminescence experiments on 1A-3A and their basic analogs, 1B-3B. This energy landscape favors 1O2 formation for 2B and 3B and leads to enhanced toxicity for these complexes under physiological conditions. The ability to convert readily from OH to O- groups allowed us to investigate an electronic change that is not accompanied by steric changes in this fundamental study.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33534562      PMCID: PMC8006600          DOI: 10.1021/acs.inorgchem.0c02027

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  46 in total

1.  Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.

Authors:  Fengrui Qu; Seungjo Park; Kristina Martinez; Jessica L Gray; Fathima Shazna Thowfeik; John A Lundeen; Ashley E Kuhn; David J Charboneau; Deidra L Gerlach; Molly M Lockart; James A Law; Katherine L Jernigan; Nicole Chambers; Matthias Zeller; Nicholas A Piro; W Scott Kassel; Russell H Schmehl; Jared J Paul; Edward J Merino; Yonghyun Kim; Elizabeth T Papish
Journal:  Inorg Chem       Date:  2017-06-21       Impact factor: 5.165

2.  New cyclometallated Ru(II) complex for potential application in photochemotherapy?

Authors:  Bryan A Albani; Bruno Peña; Kim R Dunbar; Claudia Turro
Journal:  Photochem Photobiol Sci       Date:  2014-02       Impact factor: 3.982

3.  An Overview Of Photosubstitution Reactions Of Ru(II) Imine Complexes And Their Application In Photobiology And Photodynamic Therapy.

Authors:  Jessica K White; Russell H Schmehl; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-06-18       Impact factor: 2.545

4.  Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions.

Authors:  John Roque; Dmytro Havrylyuk; Patrick C Barrett; Tariq Sainuddin; Julia McCain; Katsuya Colón; William T Sparks; Evan Bradner; Susan Monro; David Heidary; Colin G Cameron; Edith C Glazer; Sherri A McFarland
Journal:  Photochem Photobiol       Date:  2019-12-06       Impact factor: 3.421

Review 5.  Catalytic Metallodrugs: Substrate-Selective Metal Catalysts as Therapeutics.

Authors:  Zhen Yu; James A Cowan
Journal:  Chemistry       Date:  2017-08-21       Impact factor: 5.236

6.  Organometallic Ru(II) Photosensitizers Derived from π-Expansive Cyclometalating Ligands: Surprising Theranostic PDT Effects.

Authors:  Tariq Sainuddin; Julia McCain; Mitch Pinto; Huimin Yin; Jordan Gibson; Marc Hetu; Sherri A McFarland
Journal:  Inorg Chem       Date:  2015-12-16       Impact factor: 5.165

7.  Photochemical Resolution of a Thermally Inert Cyclometalated Ru(phbpy)(N-N)(Sulfoxide)+ Complex.

Authors:  Lucien N Lameijer; Corjan van de Griend; Samantha L Hopkins; Anne-Geert Volbeda; Sven H C Askes; Maxime A Siegler; Sylvestre Bonnet
Journal:  J Am Chem Soc       Date:  2018-12-26       Impact factor: 15.419

8.  Diastereoselective Synthesis and Two-Step Photocleavage of Ruthenium Polypyridyl Complexes Bearing a Bis(thioether) Ligand.

Authors:  Michael S Meijer; Sylvestre Bonnet
Journal:  Inorg Chem       Date:  2019-08-21       Impact factor: 5.165

Review 9.  Organoiridium complexes: anticancer agents and catalysts.

Authors:  Zhe Liu; Peter J Sadler
Journal:  Acc Chem Res       Date:  2014-02-20       Impact factor: 22.384

10.  Bacterial Cytological Profiling Reveals the Mechanism of Action of Anticancer Metal Complexes.

Authors:  Yang Sun; David K Heidary; Zhihui Zhang; Christopher I Richards; Edith C Glazer
Journal:  Mol Pharm       Date:  2018-06-30       Impact factor: 4.939

View more
  3 in total

1.  Light-responsive and Protic Ruthenium Compounds Bearing Bathophenanthroline and Dihydroxybipyridine Ligands Achieve Nanomolar Toxicity towards Breast Cancer Cells.

Authors:  Olaitan E Oladipupo; Spenser R Brown; Robert W Lamb; Jessica L Gray; Colin G Cameron; Alexa R DeRegnaucourt; Nicholas A Ward; James Fletcher Hall; Yifei Xu; Courtney M Petersen; Fengrui Qu; Ambar B Shrestha; Matthew K Thompson; Marco Bonizzoni; Charles Edwin Webster; Sherri A McFarland; Yonghyun Kim; Elizabeth T Papish
Journal:  Photochem Photobiol       Date:  2021-11-13       Impact factor: 3.421

Review 2.  Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.

Authors:  Elizabeth T Papish; Olaitan E Oladipupo
Journal:  Curr Opin Chem Biol       Date:  2022-04-25       Impact factor: 8.972

Review 3.  Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments.

Authors:  Brondwyn S McGhie; Janice R Aldrich-Wright
Journal:  Biomedicines       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.